Amarantus Bioscience Company Insiders
| AMBS Stock | USD 0.0001 0.00 0.00% |
Amarantus Bioscience employs about 19 people. The company is managed by 10 executives with a total tenure of roughly 46 years, averaging almost 4.0 years of service per executive, having 1.9 employees per reported executive. Breaking down Amarantus Bioscience's management performance can provide insight into the firm performance.
| Gerald Commissiong CEO CEO and President and Director |
| Robert Harris Chairman Compliance Officer, Independent Director, Chairman of Governance and Nominating Committee, Member of Compensation Committee and Member of Audit Committee |
Amarantus |
Amarantus Bioscience Management Team Effectiveness
Amarantus Bioscience's management efficiency ratios could be used to measure how well Amarantus Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Amarantus Bioscience Workforce Comparison
Amarantus Bioscience Holdings is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 365. Amarantus Bioscience holds roughly 19.0 in number of employees claiming about 5% of equities under Health Care industry.
Amarantus Bioscience Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Amarantus Bioscience Price Series Summation is a cross summation of Amarantus Bioscience price series and its benchmark/peer.
Amarantus Bioscience Notable Stakeholders
An Amarantus Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amarantus Bioscience often face trade-offs trying to please all of them. Amarantus Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amarantus Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gerald Commissiong | CEO and President and Director | Profile | |
| Robert Harris | Compliance Officer, Independent Director, Chairman of Governance and Nominating Committee, Member of Compensation Committee and Member of Audit Committee | Profile | |
| John Commissiong | Chief Scientific Officer, Director and Member of Scientific Advisory Board | Profile | |
| Paula MD | Chief Diagnostics | Profile | |
| Elise MS | VP Management | Profile | |
| Aimee Boutcher | Director Relations | Profile | |
| Brian Harvey | Chief Advisors | Profile | |
| Owen Garrick | Co Advisor | Profile | |
| Richard MD | Chief Corp | Profile | |
| Ravi Kiron | Sr Devel | Profile |
About Amarantus Bioscience Management Performance
The success or failure of an entity such as Amarantus Bioscience often depends on how effective the management is. Amarantus Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amarantus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amarantus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Please note, the imprecision that can be found in Amarantus Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amarantus Bioscience Holdings. Check Amarantus Bioscience's Beneish M Score to see the likelihood of Amarantus Bioscience's management manipulating its earnings.
Amarantus Bioscience Workforce Analysis
Traditionally, organizations such as Amarantus Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amarantus Bioscience within its industry.Amarantus Bioscience Manpower Efficiency
Return on Amarantus Bioscience Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 557.1K | |
| Net Loss Per Executive | 1.1M |
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.